降钙素原在动脉瘤性蛛网膜下腔出血后迟发性脑缺血中的意义
该前瞻性研究纳入132例动脉瘤性蛛网膜下腔出血患者,评估降钙素原对迟发性脑缺血的预测和确认价值。早期降钙素原对迟发性脑缺血及不良预后预测价值较低,但在无感染患者中迟发性脑缺血时降钙素原升高,脑梗死时二次升高。
要点
- 早期降钙素原预测迟发性脑缺血价值低(AUC 0.661)。
- 无感染患者中迟发性脑缺血时降钙素原升高(p=0.001)。
- 迟发性脑缺血相关脑梗死时降钙素原二次升高(p=0.002)。
核心结论
- 早期较高降钙素原水平与迟发性脑缺血及不良预后相关,但预测价值低。
研究设计与样本
- 前瞻性队列研究,2014至2018年纳入132例动脉瘤性蛛网膜下腔出血患者,每日记录降钙素原水平。
主要发现
- 早期降钙素原预测迟发性脑缺血的AUC为0.661(SE 0.050,p=0.003),预测不良预后的AUC为0.674(SE 0.054,p=0.003)。
- 无感染亚组(n=72)中,迟发性脑缺血患者降钙素原较高(p=0.001),迟发性脑缺血相关脑梗死患者也较高(p=0.002)。
- 迟发性脑缺血后降钙素原逐渐升高,成功干预后下降;进展为脑梗死的难治病例出现二次升高。
临床怎么用
- 降钙素原不宜单独用于预测迟发性脑缺血,需结合其他指标。
- 无感染患者中降钙素原动态变化可辅助监测迟发性脑缺血及脑梗死进展。
局限性
- 出血后数日降钙素原分析受院内感染干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysmal subarachnoid hemorrhage (aSAH) initiates a deleterious cascade activating multiple inflammatory processes, which can contribute to delayed cerebral ischemia (DCI). Procalcitonin (PCT) is an established marker for sepsis treatment monitoring, and its time course in the context of DCI after aSAH remains unclear. The aim of this trial was to assess the predictive and confirmative value of PCT levels in the context of DCI. METHODS: All patients admitted to the authors' institution with aSAH between 2014 and 2018 were prospectively screened for eligibility. Daily PCT levels were recorded alongside relevant aSAH characteristics. The predictive and confirmative values of PCT levels were assessed using a receiver operating characteristic and area under the curve (AUC) analysis. The course of PCT levels around the DCI event was evaluated in an infection-free subgroup of patients. RESULTS: A total of 132 patients with aSAH were included. Early PCT levels (first 3 days post-aSAH) had a low predictive value for the development of DCI (AUC 0.661, standard error [SE] 0.050; p = 0.003) and unfavorable long-term outcome (i.e., Glasgow Outcome Scale-Extended scores 1-4; AUC 0.674, SE 0.054; p = 0.003). In a subgroup analysis of infection-free patients (n = 72), PCT levels were higher in patients developing DCI (p = 0.001) and DCI-related cerebral infarction (p = 0.002). PCT concentrations increased gradually after DCI and decreased with successful intervention. In refractory cases progressing to cerebral infarction, PCT levels showed a secondary increase. CONCLUSIONS: Early higher PCT levels were associated with the later development of DCI and unfavorable outcome. Analysis of PCT beyond the first couple of days after hemorrhage is hampered by nosocomial infections. In infection-free patients, however, PCT levels rise during DCI and an additional increase develops in patients developing cerebral infarction. Clinical trial registration no.: NCT02142166 (clinicaltrials.gov).
引用
- Veldeman M, Lepore D, Höllig A, et al. Procalcitonin in the context of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2020. PMID: 32886914. doi:10.3171/2020.5.JNS201337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。